Enrica Marchi, MD Discusses Using Case Match Control in Orphan Diagnoses
Enrica Marchi, MD
At the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Rare Disease Report sat down with Enrica Marci, MD of the Columbia University School of Medicine to discuss her study with Owen O'Connor, MD, Innovative approach to determine overall survival benefit for orphan diseases using case match control analyses using case match control in diagnosing orphan diseases.
Among the questions asked were:
Can all lymphomas be considered rare? (0:01)
How is case match analyses an innovative approach to determining overall survival benefit for orphan diseases? (0:27)
How can physicians get creative with outcome measures for small patient populations? (1:52)